FDA rejects Orexigen’s diet pill, orders new clinical trial

FDA rejects Orexigen’s diet pill, orders new clinical trial
The decision was a huge disappointment to the La Jolla company’s executives and shareholders, who believed Contrave had the best chance out of three experimental weight-loss medications to become the first new diet pill approved for the U.S. market in more than a decade.
Read more on San Diego Union-Tribune

FDA declines to approve Orexigen diet drug
(02-01) 05:46 PST WASHINGTON (AP) — Orexigen Therapeutics Inc. said Tuesday that U.S. health officials declined to approve the experimental weight loss pill Contrave and want the company to conduct an additional study…
Read more on San Francisco Chronicle

EXCLUSIVE: CBS Orders More ‘Mike & Molly,’ ‘Rules’ to Replace ‘Two and a Half Men’
Kim Masters These extra shows will fill in a schedule with sudden holes caused by the absence of Charlie Sheen, who is seeking treatment. read more
Read more on The Hollywood Reporter